Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFFWD.L Regulatory News (FFWD)

  • There is currently no data for FFWD

Placing

3 Aug 2018 08:00

RNS Number : 7486W
FastForward Innovations Limited
03 August 2018
 

For Immediate Release

3 August 2018

FastForward Innovations Limited

("FastForward" or the "Company")

 

Placing

Director Dealing

 

Further to the announcement by FastForward Innovations Limited (AIM: FFWD) on 1 August 2018, the Company is pleased to announce that it has today agreed to place 30,769,230 new Ordinary Shares of 1p each (the "Placing Shares") at a price of 13p per Placing Share with a number of new and existing investors thereby raising gross proceeds of £4,000,000 (US$5,240,000 at an exchange rate of £1:US$1.31, being the rate on the date the Company determined the terms of the placing) before expenses (the "Placing"). The Placing Price represents a premium of approximately 27.7% to the Company's most recently published NAV per share of 10.18p. The Placing is being done by way of a placing through the Company's brokers and a direct subscription by the Company (together the "Placing"). The net proceeds of the Placing will be used to repay the Director's Loan announced on 23 July 2018, assist the Company in making investments in accordance with its investing policy and for general working capital purposes.

 

Subject to payment, application for the Placing Shares (which will rank pari passu with the existing Ordinary Shares) to be admitted to trading on AIM ("Admission") will be made with dealings expected to commence at 8.00 a.m. on 10 August 2018.

 

The Company expects that the enlarged issued share capital following the issue of the Placing Shares will be 166,913,727 Ordinary Shares (the "Enlarged Issued Share Capital").

 

The Company is reviewing its options to allow Shareholders the ability to subscribe for new Ordinary Shares on the same terms as the Placing and expects to update investors on this shortly.

 

Commenting on the Placing, Chief Executive Officer Lorne Abony noted:

 

"The placing funds allow the Company to take advantage of potential opportunities for new and follow on investments. I am pleased to see the support the Board and existing significant Shareholders have provided and see this as a vote of confidence in what we are building.

 

It is disappointing that the share price did not pick up after the recent newsflow, and that this round of funding is at 13p. For this reason the Board is committed to providing an opportunity for existing shareholders to also participate on the same terms. The intention had been to complete the Placing at a higher price but the share price did not react as expected after the Vogogo, Leap, Intensity and Factom investments, which the Board maintain are excellent investment opportunities. Similarly, whilst the pricing of the deal was disappointing for all concerned, the Company thanks investors for their support and will continue to pursue best in class investment opportunities inline with its investing policy, including within the Blockchain, Medical Cannabis and Artificial Intelligence sectors which the board believes offers the highest growth potential at present."

 

 

Related Party Transaction

 

Mr Lorne Abony and Mr Jim Mellon (who are each Directors of the Company) have participated in the Placing. The participation of the Directors is as set out below:

 

Name

Subscription

Placing Shares

Total Ordinary Shares (inc. Placing Shares)

 

% interest in the Enlarged Issued Share Capital (excluding those shares held in Treasury)

Lorne Abony1

£487,000

3,746,154

15,994,588

9.90%

Jim Mellon2

£761,505

5,857,731

16,283,722

10.08%

Lorne Abony's interest in shares is held by Abony Enterprises Limited Partnership, a limited partnership of which he is the majority legal owner.

Mr Mellon's interest in the Company's shares is held by Galloway Limited, a company owned by a trust of which Mr James Mellon is a life tenant, in respect of 10,425,991 shares and directly by Mr Mellon in respect of 5,857,731 shares.

 

The Directors are related parties for the purposes of the AIM Rules. The participation of the two Directors in the Placing constitutes a Related Party Transaction under Rule 13 of the AIM Rules for Companies.

 

Accordingly, Mr Ian Burns, the Company's Finance Director (Mr Edward McDermott, Non-Executive Director, is an employee of the Company's Brokers, Optiva Securities Limited, and so is not regarded as independent for the purposes of the Placing), is the independent director of the Company for the purposes of the Placing. Mr Ian Burns confirms that, having consulted with the Company's Nominated Adviser, the terms of the Placing are fair and reasonable insofar as the Company's shareholders are concerned. In particular Mr Burns notes that the Directors have participated on the same terms as all other placees.

 

The Investors

 

In addition to Mr Abony and Mr Mellon, following the issue of the Placing Shares the following shareholder will be interested in more than 3 per cent. of the Enlarged Issued Share Capital (excluding those shares held in Treasury):

 

Name

Subscription

Placing Shares

Total Ordinary Shares (inc. Placing Shares)

 

% interest in the Enlarged Issued Share Capital (excluding those shares held in Treasury)

LOM Nominees

£761,505

5,857,731

5,857,731

3.63%

 

 

Issued Shares

 

Following Admission of the Placing Shares, the Company's issued share capital consists of 166,913,727Ordinary Shares. 5,413,623 Ordinary shares are held in Treasury. For reporting under the FCA's Disclosure and Transparency Rules, Shareholders should exclude any shares held in Treasury and should use the figure of 161,500,104 Ordinary Shares (the issued voting share capital) when determining if they are required to notify their interest, or a change of their interest in the Company.

 

The Market Abuse Regulation ("MAR") became effective from 3 July 2016. Market soundings, as defined in MAR, were taken in respect of the Fundraise with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement and has been disclosed as soon as possible in accordance with paragraph 7 of article 17 of MAR. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities.

 

 

For further information on the Company please visit www.fstfwd.co or contact:

FastForward Innovations Limited

info@fstfwd.co

Sue Saunders / Ian Burns

 

Beaumont Cornish Limited (Nomad)

James Biddle / Roland Cornish

Tel: +44 207 628 3396

 

Optiva Securities Limited (Broker)

Graham Dickson Tel: +44 (0) 203 137 1902

 

 

 

DISCLAIMER

 

Beaumont Cornish Limited, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively as Nominated adviser to FastForward Innovations Limited and no one else in connection with the Placing and will not be responsible to anyone other than FastForward Innovations Limited for providing the protections afforded to clients of Beaumont Cornish Limited nor for providing advice in relation to the Placing. Neither Beaumont Cornish Limited nor any of its affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Beaumont Cornish Limited in connection with this Announcement, any statement contained herein, or otherwise.

 

CAUTIONARY STATEMENT

 

The AIM Market of London Stock Exchange plc does not accept responsibility for the adequacy or accuracy of this release. No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein. All statements, other than statements of historical fact, in this news release are forward-looking statements that involve various risks and uncertainties, including, without limitation, statements regarding potential values, the future plans and objectives of FastForward Innovations Limited. There can be no assurance that such statements will prove to be accurate, achievable or recognisable in the near term.

Actual results and future events could differ materially from those anticipated in such statements. These and all subsequent written and oral forward-looking statements are based on the estimates and opinions of management on the dates they are made and are expressly qualified in their entirety by this notice. FastForward Innovations Limited assumes no obligation to update forward-looking statements should circumstances or management's estimates or opinions change.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEGLGDISUGBGIX
Date   Source Headline
12th Jul 20216:15 pmRNSUpdate on timetable for Change of Name
9th Jul 20214:00 pmRNSResult of EGM and Change of Name
7th Jul 20217:00 amRNSFurther Investment in South West Brands Limited
6th Jul 20217:00 amRNSInvestment in cannabis healthcare company- CiiTECH
5th Jul 20217:00 amRNSNew investment - European medical cannabis company
28th Jun 20217:30 amRNSSale of Shares in Portage Biotech
28th Jun 20217:00 amRNSFurther Investment in Little Green Pharma Ltd
22nd Jun 20213:30 pmRNSNotice of EGM & Proposed Change of Name
22nd Jun 20213:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
10th Jun 20217:00 amRNSPurchase of further shares in Little Green Pharma
1st Jun 20217:00 amRNSInvestee Company Update: Yooma Wellness Inc.
28th May 20217:00 amRNSInvestee Company Update: Little Green Pharma
29th Apr 20217:00 amRNSInvestee Company Update: Yooma Wellness
12th Apr 20219:00 amRNSSpecialist Appointed to Strengthen Team
7th Apr 20214:25 pmRNSCompletion of Sale of Investment in EMMAC
1st Apr 20217:00 amRNSNew Investment in Cannabis Cultivator Company
22nd Mar 20213:26 pmRNSInvestee Company Update: Yooma Wellness
18th Mar 20211:55 pmRNSInvestee Company Update: Yooma Wellness Inc.
15th Mar 20217:00 amRNSInvestee Company Update: Leap Gaming
11th Mar 20218:00 amRNSSale of Investments in Kanabo and Cellular Goods
10th Mar 20217:00 amRNSConditional Sale of Investment in EMMAC
8th Mar 202110:21 amRNSInvestee Update: Portage Biotech & Juvenescence
3rd Mar 20217:00 amRNSNew Corporate Presentation
2nd Mar 20212:06 pmRNSInvestee Update: EMMAC Life Sciences and Yooma
1st Mar 20217:00 amRNSNew Investment in Consumer Cannabinoid Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20214:30 pmRNSHolding(s) in Company
26th Feb 20217:15 amRNSInvestor Presentation
26th Feb 20217:00 amRNSCorporate Update
23rd Feb 20214:40 pmRNSSecond Price Monitoring Extn
23rd Feb 20214:35 pmRNSPrice Monitoring Extension
22nd Feb 20218:15 amRNSHolding(s) in Company
18th Feb 20212:05 pmRNSSecond Price Monitoring Extn
18th Feb 20212:00 pmRNSPrice Monitoring Extension
18th Feb 20219:37 amRNSInvestee Company Update: Little Green Pharma Ltd
16th Feb 20212:00 pmRNSPrice Monitoring Extension
16th Feb 202112:20 pmRNSInvestment in Medical Cannabis Company
12th Feb 20217:00 amRNSNew Investment in Medical Cannabis Business
11th Feb 20213:44 pmRNSInvestee Company Update: Portage Biotech Inc.
11th Feb 202110:33 amRNSInvestee Company Update: Yooma Corp.
2nd Feb 202111:09 amRNSInvestee Company Update: Leap Gaming
1st Feb 20217:00 amRNSInvestment - CBD Brand Business, South West Brands
29th Jan 202110:40 amRNSPlacing to raise £2.1 million
26th Jan 20214:12 pmRNSInvestee Company Update: EMMAC Life Sciences
26th Jan 20212:14 pmRNSInvestee Company Update: Yooma Corp.
20th Jan 202112:00 pmRNSInvestee Update: EMMAC Life Sciences & Yooma Corp.
16th Dec 20207:00 amRNSFurther Investment in EMMAC Life Sciences Group
10th Dec 20207:00 amRNSInterim Results
30th Nov 20207:00 amRNSEd McDermott Appointed to the Board of Leap Gaming
24th Nov 20207:00 amRNSInvestee Company Update: Yooma Corp.

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.